Professional Documents
Culture Documents
#1 Female - Vagina-Cervix - Sahar Samaha MD
#1 Female - Vagina-Cervix - Sahar Samaha MD
Trichomoniasis
Candida albicans infection
The vaginal mucosa is inflamed and often speckled with
petechial lesions. Sexually transmitted, high carrier. In
adolescents, petechial hemorrhages may also be found on
the cervix, resulting in the so-called strawberry cervix
Trichomoniasis
Chlamydia trachomatis
Ascending infection
Papillary or tree-like
Koilocytosis which is a perinuclear
cytoplasmic vacuolization and nuclear wrinkling
Acanthosis and parakeratosis
Pathogenesis
NORMAL LSIL
(Lower 1/3 and/or Koilocytes)
HSIL
(More than 1/3)
Cervical intraepithelial neoplasia
CIN is a precancerous
epithelial lesion that may
progress to overt cancer
◼ LSIL (low-grade squamous
intraepithelial lesions), which
is CIN I.
◼ HSIL (high-grade squamous
intraepithelial lesions), which
is CIN II and CIN III
(Expansion of immature basal cells
to the epithelial surface)
Human papillomavirus (HPV)
❖ Double stranded DNA virus
❖ 50% of HPV infections cleared in 8 months and 90% in 2 years (mostly low risk subtypes)
❖ HPV infects basal layer of transition zone but replication of HPV DNA occurs in more mature cells.
❖ Due to expression of E6 and E7, two oncoproteins which bind and inactivate 2 tumor suppressors: p53
and Rb, preventing cell cycle arrest and promoting carcinogenesis.
Grouped into:
▪ low risk (6,11), . Associated with development of condyloma,
. No integration with cell genome (rare progression to cancer <1%)
▪ High risk (16,18) (frequent progression to cancer, >20%)
. The virus encodes several proteins including E6 and E7, integrates into cell genome, causing inhibition of
the cell cycle regulatory proteins (p53 & Rb)
. Immunosuppression is the highest risk factor
. Lack of barrier contraception
Looking for HPV in biopsies
p16
Morphology
• Koilocytes (low risk, 6/11)
• Immunohistochemistry
In situ hybridization for HPV
Nucleic acid hybridization to allow for localization in tissue
p16 Immunohistochemistry
Surrogate marker of HPV
Accumulates in transformed cells
Sensitive but not entirely specific for HPV
Prevention: HPV vaccine
Two HPV vaccines are currently on the market: Gardasil and
Cervarix.
Both vaccines protect against HPV-16 and 18; GARDISIL
also against HPV-6 and 11.
Both vaccines have been shown to prevent precancerous
lesions of the cervix.
HPV vaccine is recommended for young women to prevent
cervical cancer and condyloma
Boys, like girls, should get the two doses of the HPV
vaccine at age 11 or 12
Continued Pap test necessary to detect those already
infected and those caused by other sub-types (31 and 33)
Squamous cell carcinoma
Cervical Squamous cell carcinoma
Risk factors for progression
Cigarette smoking, HIV, HPV, Herpes, Age, Socioeconomic factors,
exposure to diethylstilbestrol (DES)
Diagnosis: Lesions must be biopsied to determine if invasive lesion present.
Range from microscopic tumors to exophytic tumors.
Present with vaginal bleeding, leucorrhea, dyspareunia or dysuria,
Treatment varies from cone biopsy to hysterectomy and lymph node
dissection.
Mortality linked to tumor stage.
Renal complications and failure a significant cause of morbidity
Invasive squamous cell carcinoma